Process for typing of hcv isolates
CA 2128528 C · Owner: Stuyver, Lieven · Inventors: Stuyver, Lieven; Van Heuverswyn, Hugo; Maertens, Geert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a process for genotyping any HCV isolate present in a biological sample, previously identified as being HCV positive, and for classifying said isolate according to the percentage of homology with other HCV isolates, comprising the steps of: contacting said sample in which the ribonucleotides or deoxyribonucleotides have been made accessible if need be, under suitable , denaturation with at least one probe from about 10 to about 40 nucleotides with said probe being liable to hybridize to a region being in the domain extending from nucleotide at position -291 to nucleotide at position -66 of the 5' untranslated region of one of the HCV isolates represented by …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 26, 1993 and granted February 14, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 26, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 26, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.